4520 Federal Register / Vol. 72, No. 20 / Wednesday, January 31, 2007 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 

Comment Request; California Health 

Interview Survey 2007 

Summary: Under the provisions of 

Section 3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Cancer Institute (NCI), the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request to review and approve 

the information collection listed below. 

This proposed information collection 

was previously published in the Federal 

Register on Sept. 11, 2006, p. 53456 and 

allowed 60-days for public comment. 

No public comments were received. The 

purpose of this notice is to allow an 

additional 30 days for public comment. 

The National Institutes of Health may 

not conduct or sponsor, and the 

respondent is not required to respond 

to, an information collection that has 

been extended, revised, or implemented 

on or after October 1, 1995, unless it 

displays a currently valid OMB control 

number. 

Proposed collection 

Title: California Health Interview 

Survey 2007. 

Type of Information Collection 

Request: NEW. 

Need and use of Information 

Collection: The NCI has sponsored three 

Cancer Control Modules in the 

California Health Interview Survey 

(CHIS), and will be sponsoring a fourth 

to be administered in 2007. Other 

federal government agencies have cosponsored previous cycles of the survey. 

The CHIS is a telephone survey 

designed to provide population-based, 

standardized health-related data to 

assess California’s progress in meeting 

Healthy People 2010 objectives for the 

nation and the state. The CHIS samples 

designed to provide statisticically 

reliable estimates statewide, for 

California counties, and for California’s 

ethnically and racially diverse 

population. Initiated by the UCLA 

Center for Health Policy Research, the 

California Department of Health 

Services, and the California Public 

Health Institute, the survey is funded by 

a number of public and private sources. 

It was first administered in 2001 to 

55,428 adults, 5,801 adolescents, and 

12,802 children; subsequently in 2003 

to 42,043 adults, 4,010 adolescents, and 

8,502 children; and in 2005 to 43,020 

adults, 4,029 adolescents, and 11,358 

children. These individuals are a 

representative sample of California’s 

non-institutionalized population living 

in households. 

CHIS 2007, is the fourth bi-annual 

survey, is planned for administration to 

48,000 adult Californians and 4,000 

adolescents. The cancer control module, 

which is similar to that administered in 

CHIS 2001, CHIS 2003, and CHIS 2005, 

will allow NCI and other Federal 

agencies to examine various health- and 

disease-related topics. Examples include 

patterns and (when fielded in multiple 

years) trends in breast cancer screening, 

diet, physical activity, obesity, tobacco 

control and other disease risk factors, 

disease outcomes, discrimination, and 

neighborhood cohesion. 

Because California is the most 

populous and the most racially and 

ethnically diverse state in the nation, 

the CHIS 2007 sample will yield 

adequate numbers of respondents in key 

ethnic and racial groups, including 

African Americans, Latinos, Asians, and 

American Indian/Alaska Natives. The 

Latino group will include large numbers 

of respondents in the Mexican, Central 

American, South American, and other 

Latino subgroups; the Asian group will 

include large numbers of respondents in 

the Chinese, Filipino, Japanese, 

Vietnamese, and Korean subgroups. NCI 

and other Federal agencies will use the 

California and National Health 

Interview Survey (CHIS, NHIS) data to 

conduct comparative analyses and 

better estimate cancer risk factors and 

screening among racial/ethnic minority 

populations. The CHIS sample size also 

permits NCI and other federal agencies 

to obtain estimates for ethnic 

subdomains of the population for which 

NHIS has insufficient numbers for 

analysis. 

Frequency of Response: One-time. 

Affected public: Individuals or 

households. 

Types of Respondents: U.S. adults 

(persons 18 years of age and older) and 

adolescents (persons of age 12–17 for 

whom the adult respondent is the 

parent or legal guardian of the 

adolescent residing in the household). 

The annual reporting burden is as 

follows: 

Estimated Number of Respondents: 

48,000 Adults and 4,000 Adolescents. 

Estimated Number of Response per 

Respondent: 1. 

Average Burden Hours per Response: 

.1202 for Adults and .0134 for 

Adolescents. 

Estimated Total Burden Hours 

Requested: 5,778 for Adults and 53.8 for 

Adolescents. The annualized cost to 

respondents is estimated at $98,629.451. 

There are no Capital Costs to report. 

There are no Operating or Maintenance 

Costs to report. 

TABLE A.—ANNUALIZED BURDEN ESTIMATES FOR CHIS 2007 DATA COLLECTION

Type of respondent 

Estimated 

number of 

respondents 

Estimated 

number or 

responses per 

respondent 

Average 

burden hour 

per response 

Estimated 

total annual 

burden hours 

Adult Pilot ......................................................................................................... 150 1 .1200 18.0 

Adult Survey .................................................................................................... 48,000 1 .1200 5760.0 

Adolescent Pilot ............................................................................................... 15 1 .0134 .2 

Adolescent Survey ........................................................................................... 4,000 1 .0134 53.6 

Total .......................................................................................................... ........................ ........................ ........................ 5831.8 

Request for Comments: Written 

comments and/or suggestions from the 

public and affected agencies are invited 

on one or more of the following points: 

(1) Whether the proposed collection of 

information is necessary for the proper 

performance of the function of the 

agency, including whether the 

information will have practical utility; 

(2) The accuracy of the agency’s 

estimate of the burden of the proposed 

collection of information, including the 

validity of the methodology and 

assumptions used; (3) Ways to enhance 

the quality, utility, and clarity of the 

information to be collected; and (4) 

Ways to minimize the burden of the 

collection of information on those who 

mstockstill on PROD1PC62 with NOTICES

Federal Register / Vol. 72, No. 20 / Wednesday, January 31, 2007 / Notices 4521 

are to respond, including the use of 

appropriate automated electronic, 

mechanical, or other technological 

collection techniques or other forms of 

information technology. 

Direct Comments to OMB: Written 

comments and/or suggestions regarding 

the item(s) contained in this notice, 

especially regarding the estimated 

public burden and associated response 

time, should be directed to the Office of 

Management and Budget, Office of 

Regulatory Affairs, New Executive 

Office Building, Room 10235, 

Washington, DC 20503, Attention: Desk 

Officer for NIH. To request more 

information on the proposed project or 

to obtain a copy of the data collection 

plans and instruments, contact: Dr. 

Nancy Breen, Ph.D., Project Officer, 

Applied Research Program, Division of 

Cancer Control and Population Sciences 

NCI, NIH, EPN 4005, 6130 Executive 

Boulevard MSC 7344. Bethesda, 

Maryland 20852–7344, or call the nontoll-free number 301–696–8500 or Email your request, including your 

address to breenn@mail.nih.gov. 

Comments Due Date: Comments 

regarding this information collection are 

best assured of having their full effect if 

received within 30 days of the date of 

this publication. 

Dated: January 23, 2007. 

Rachelle Ragland-Greene, 

NCI Project Clearance Liaison, National 

Institutes of Health. 

[FR Doc. 07–406 Filed 1–30–07; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Call for 

Nominations for the National Cancer 

Institute Director’s Consumer Liaison 

Group 

The National Cancer Institute (NCI) 

the Federal Government’s primary 

agency for cancer research, is seeking 

nominations for four (4) new members 

of the NCI Director’s Consumer Liaison 

Group (DCLG) which will be appointed 

in July, 2007. The DCLG helps NCI to 

identify appropriate advocates to serve 

on its program and policy advisory 

committees. 

The National Cancer Institute (NCI) 

formed the NCI Director’s Consumer 

Liaison Group (DCLG) in 1998 to advise 

and make recommendations to the NCI 

Director, from the perspective and 

viewpoint of cancer consumer 

advocates, on a wide variety of issues, 

programs, and research priorities. The 

DCLG gives cancer advocates a channel 

to voice their views and concerns. The 

DCLG is a 16-member chartered federal 

advisory committee that works with NCI 

to ensure that those who experience the 

burden of cancer also help to shape the 

course of the NCI’s research to eradicate 

it. Specifically the DCLG members: 

• Help develop and establish 

processes, mechanisms and criteria for 

identifying appropriate consumer 

advocates to serve on a variety of 

program and policy advisory 

committees responsible for advancing 

the mission of the NCI. 

• Serve as a primary forum for 

discussion issues and concerns and 

exchanging viewpoints that are 

important to the broad development of 

the NCI programming and research 

priorities. 

• Establish and maintain strong 

collaborations between the NCI and the 

cancer advocacy community to reach 

common goals. 

Eligibility Requirements: NCI looks for 

strong, highly qualified candidates who 

fulfill the following eligibility criteria: 

• Demonstrate involvement in the 

cancer experience as a cancer survivor, 

a caregiver to someone who has cancer, 

or as a professional or volunteer who 

works with cancer survivors, patients, 

or caregivers; 

• Have a constituency with which 

she/he regularly communicates on 

cancer issues and with which she/he is 

able to serve as a conduit for 

information, both to and from NCI. 

Nominees who meet the minimum 

eligibility requirements will be 

evaluated further based on the following 

qualities: 

• Cancer advocacy experience; ability 

to represent all cancer survivors; 

• Possession of strong leadership, 

communication, and collaboration 

skills; 

• Ability to advise on broad cross 

cutting cancer issues; 

• Ability to facilitate dialogue 

between NCI and the cancer advocacy 

community. 

DCLG members must be committed to 

participating in all activities of the 

DCLG which includes at least two 

meetings a year in Bethesda, MD. 

Characteristics of the DCLG. In 

addition to the criteria for individual 

candidates, the following characteristics 

of the DCLG as a group are balanced to 

ensure that it reflects the breadth and 

diversity of the consumer advocacy 

community: 

• Racial and ethnic balance 

• A broad mix of cancer sites 

• Expertise with advocacy 

organizations (local, regional, or 

national) 

• Geographical diversity 

• Gender 

• Age diversity 

Selection Process. A call for 

nominations is disseminated annually 

to a broad range of groups, including 

local, regional and national 

organizations, to encourage nominations 

of candidates reflecting the diversity 

sought for the DCLG. Individuals may 

nominate themselves. All nominees are 

screened for eligibility, and then 

evaluated according to the criteria. A 

list of highly qualified candidates who 

reflect balance and diversity of 

representation is forwarded to the 

Director, NCI who selects the DCLG 

members. The original members of the 

DCLG endorsed this process and the 

criteria developed to evaluate the 

applications of potential DCLG 

members, and this process is used to 

select future members. 

To receive a nomination package for 

the DCLG, send your name, advocacy/ 

voluntary organization affiliation (if 

any), address, phone number and E-mail 

information to: Palladian Partners, Inc., 

Attn: DCLG 2007 Selection Process, 

1010 Wayne Avenue, Suite 1200, Silver 

Spring, MD 20910, Phone: (301) 650–

8660, Fax: (301) 650–8676. 

Nominations must be postmarked by 

March 30, 2007. 

Dated: January 23, 2007. 

Anna Snouffer, 

Acting Director, Office of Federal Advisory 

Committee Policy, National Institutes of 

Health. 

[FR Doc. 07–400 Filed 1–30–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the National Cancer 

Institute Special Emphasis Panel, 

February 27, 2007, 12 p.m. to February 

27, 2007, 4 p.m., National Institutes of 

Health, 6130 Executive Blvd., Rockville, 

MD 20852 which was published in the 

Federal Register on December 28, 2006, 

71 FR 78214. 

The meeting notice is changed to 

reflect the change in the name of the 

committee from ‘‘SBIR Topic 230 

(Phases I & II)’’ to ‘‘SBIR, Synthesis 

Stable Isotope-Labeled Steroids as 

Internal Standards.’’ The meeting is 

closed to the public. 

mstockstill on PROD1PC62 with NOTICES